Zurex Pharma Inc., a Middleton, Wisc.-based life sciences company, has raised $6.2 million in Series A financing. Baird Venture Partners and the State of Wisconsin Investment Board led the round, with participation from Wisconsin Investment Partners, Peak Ridge Capital and unnamed individuals. The company will use the money to develop and commercialize its products, which are designed to “prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.”
